Company Filing History:
1 out of 104 
1 out of 1 Years Active: 2008
Title: The Innovations of David Cavanagh
Introduction
David Cavanagh is a notable inventor based in Newbury, GB. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for poultry. His work focuses on addressing infectious diseases that affect livestock, ensuring better health and productivity in the agricultural sector.
Latest Patents
Cavanagh holds a patent for an innovative vaccine designed to protect poultry against infectious bronchitis. This vaccine comprises an attenuated infectious bronchitis virus (IBV) and a pharmaceutical acceptable carrier or diluent. The unique aspect of this invention is that the attenuated IBV includes a heterologous spike gene. This vaccine is based on the IBV strain Beaudette, which can express a spike gene derived from a different IBV strain. Additionally, the vaccine allows for administration via the in ovo route, enhancing its effectiveness in poultry health management.
Career Highlights
Throughout his career, David Cavanagh has worked with reputable organizations such as Intervet International B.V. and the Institute for Animal Health. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to advancements in veterinary science.
Collaborations
Cavanagh has collaborated with notable colleagues, including Paul Britton and Ian Tarpey. Their combined expertise has furthered research and development in the area of infectious diseases in poultry.
Conclusion
David Cavanagh's contributions to vaccine development for poultry highlight his commitment to improving animal health. His innovative approach and collaboration with other experts have made a significant impact in the field of veterinary medicine.